30 October 2015 - Rekovelle is a novel human recombinant follicle-stimulating hormone intended for controlled ovarian stimulation in women undergoing assisted reproductive technology therapy such as in vitro fertilisation or intracytoplasmic sperm injection.

For more details, go to: https://www.ferring.com/en/media/press-releases/2015/rekovelle-marketing-authorisation-30-oct-15/